The FDA has approved Linzess (linaclotide) for treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older.
Find out about L-glutamine's potential benefits in IBS-D and post-infectious IBS, and learn how it may enhance gut health and ...
Irritable Bowel Syndrome (IBS) is a common digestive disorder affecting approximately 7% of the Indian population. This functional gastrointestinal disorder manifests through symptoms like abdominal ...
When life gets hectic, nutrition often falls by the wayside. While one off-schedule week isn’t necessarily harmful to your ...